GGrantIndex
Sort

40,608 grants matching prostate cancer

Preventing Falls and Frailty in Prostate Cancer Survivors: GET FIT Prostate

$635,011
Kerri M Winters-Stone · Oregon Health & Science University · R01 · FY2019 · CA

Targeting Non-Canonical STING Signaling to Treat SPOP Mutant Castration-Resistant Prostate Cancer

$634,907
Timothy C Thompson · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA

Leveraging whole-exome sequence data from diverse biobanks and cohorts to study rare coding variation in prostate cancer

$634,844
Christopher Alan Haiman · University Of Southern California · R01 · FY2024 · CA

Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy

$634,819
Kosj Yamoah · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2024 · CA

Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)

$634,802
Jim Hu · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

Highly selective targeted theranostics for prostate cancers

$634,753
James Peter Basilion · Case Western Reserve University · R01 · FY2024 · CA

Data Processing, Analysis and Modeling Unit

$634,712
Jeremy Goecks · Oregon Health & Science University · U2C · FY2019 · CA

Data Processing, Analysis and Modeling Unit

$634,673
Jeremy Goecks · Oregon Health & Science University · U2C · FY2018 · CA

WHOLE EXOME SEQUENCING FOR NCI (COZEN)

$634,550
Kimberly F Doheny · Johns Hopkins University · N01 · FY2023 · HL

Targeting the Plk1/Pdcd4/mTORC2 Signaling to Treat Castration-Resistant Prostate Cancer

$634,489
Xiaoqi Liu · University Of Kentucky · R01 · FY2023 · CA

Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development

$634,446
Owen N Witte · University Of California Los Angeles · R01 · FY2022 · CA

TANSHINONES AS EFFECTIVE THERAPEUTIC AGENTS FOR PROSTATE CANCER

$634,367
Beth Israel Deaconess Medical Center, Inc. · · FY2008 · Department of the Army

A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence

$634,348
John V Frangioni · Beth Israel Deaconess Medical Center · R01 · FY2013 · CA

A Systems Biology Approach to the Development of Cancer Biomarkers

$634,323
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · U01 · FY2013 · CA

PRECISION TARGETING OF CASTRATION-RESISTANT PROSTATE CANCER WITH A NOVEL FERROUS IRON-DEPENDENT THERAPEUTIC DELIVERY AND TUMOR IMAGING STRATEGY

$634,294
Regents Of The University Of California, San Francisco, The · · FY2018 · Department of the Army

Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics

$634,266
David J Beebe · University Of Wisconsin-Madison · R01 · FY2021 · CA

Strategies for Cancer Immunotherapy Clinical Trials

$634,145
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Strategies for Cancer Immunotherapy Development: Preclinical Studies

$634,145
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

LARGE ONCOSOMES: A NOVEL LIQUID BIOPSY FOR GENETIC PROFILING IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

$634,128
Cedars-Sinai Medical Center · · FY2016 · Department of the Army

Improving Efficacy of RNase Cancer Therapy by Pharmacokinetics

$634,106
Mark N Shahan · Quintessence Biosciences, Inc. · R44 · FY2009 · CA

Early Detection and Diagnosis of Lung Cancer with Endomicroscopy

$633,891
Melissa J Suter · Massachusetts General Hospital · R01 · FY2022 · CA

Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology

$633,774
Vadim Backman · Northwestern University · R01 · FY2017 · CA

MICRO RNA IN PROSTATE CANCER RACIAL DISPARITY

$633,750
New York University · · FY2009 · Department of the Army

A SIGNAL PATHWAY-BASED SIGNATURE FOR METASTATIC PROSTATE CANCER

$633,750
New York University · · FY2012 · Department of the Army

Caregiver Coping Skills training for Lung Cancer

$633,747
Duke University · R01 · FY2003 · CA